Zacks Investment ResearchWed, 27 May 2026 15:21:05 GMTDyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD TherapyDYN+4.15%
Seeking AlphaThu, 21 May 2026 18:37:15 GMTDyne Therapeutics: 'Strong Buy' Due To Upcoming Z-Rostudirsen BLA SubmissionDYN+4.15%
Zacks Investment ResearchThu, 21 May 2026 16:36:13 GMTDyne Stock Gains 10% on Initiation of Late-Stage Study in DMD PatientsDYN+4.15%
Zacks Investment ResearchMon, 11 May 2026 17:01:15 GMTDyne Therapeutics (DYN) Upgraded to Buy: Here's What You Should KnowDYN+4.15%
Seeking AlphaMon, 09 Mar 2026 19:27:58 GMTDyne Therapeutics, Inc. (DYN) Presents at TD Cowen 46th Annual Health Care Conference Prepared Remarks TranscriptDYN+4.15%
Seeking AlphaMon, 09 Mar 2026 17:30:15 GMTDyne Therapeutics: Strong DELIVER Data Strengthens The Bull CaseDYN+4.15%
The Motley FoolMon, 02 Mar 2026 17:33:46 GMTInvestment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC FilingDYN+4.15%
